OMB APPROVAL |
||
OMB Number: 3235-0145 |
||
Expires: February 28, 2006 |
||
Estimated average burden hours per response...11 |
||
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
SCHEDULE 13G
Under the Securities Exchange Act of 1934
(Amendment No. 1)*
Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
o Rule 13d-1(b)
o Rule 13d-1(c)
þ Rule 13d-1(d)
* The remainder of this cover page shall be filled out for a reporting persons initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.
The information required in the remainder of this cover page shall not be deemed to be filed for the purpose of Section 18 of the Securities Exchange Act of 1934 (Act) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.
CUSIP No. |
88078l 10 5 |
1 | NAMES OF REPORTING PERSONS: MPM BioVentures III, L.P. |
||||
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY): | |||||
2 | CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS): |
||||
(a) o | |||||
(b) þ | |||||
3 | SEC USE ONLY: | ||||
4 | CITIZENSHIP OR PLACE OF ORGANIZATION: | ||||
Delaware | |||||
5 | SOLE VOTING POWER: | ||||
NUMBER OF | 383,776 | ||||
SHARES | 6 | SHARED VOTING POWER: | |||
BENEFICIALLY | |||||
OWNED BY | 0 | ||||
EACH | 7 | SOLE DISPOSITIVE POWER: | |||
REPORTING | |||||
PERSON | 383,776 | ||||
WITH: | 8 | SHARED DISPOSITIVE POWER: | |||
0 | |||||
9 | AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON: | ||||
383,776 | |||||
10 | CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS): | ||||
o | |||||
11 | PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9): | ||||
1.2% | |||||
12 | TYPE OF REPORTING PERSON (SEE INSTRUCTIONS): | ||||
PN |
Page 2 of 14
CUSIP No. |
88078l 10 5 |
1 | NAMES OF REPORTING PERSONS: MPM BioVentures III-QP, L.P. |
||||
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY): | |||||
2 | CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS): |
||||
(a) o | |||||
(b) þ | |||||
3 | SEC USE ONLY: | ||||
4 | CITIZENSHIP OR PLACE OF ORGANIZATION: | ||||
Delaware | |||||
5 | SOLE VOTING POWER: | ||||
NUMBER OF | 5,707,936 | ||||
SHARES | 6 | SHARED VOTING POWER: | |||
BENEFICIALLY | |||||
OWNED BY | 0 | ||||
EACH | 7 | SOLE DISPOSITIVE POWER: | |||
REPORTING | |||||
PERSON | 5,707,936 | ||||
WITH: | 8 | SHARED DISPOSITIVE POWER: | |||
0 | |||||
9 | AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON: | ||||
5,707,936 | |||||
10 | CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS): | ||||
o | |||||
11 | PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9): | ||||
18.0% | |||||
12 | TYPE OF REPORTING PERSON (SEE INSTRUCTIONS): | ||||
PN |
Page 3 of 14
CUSIP No. |
88078l 10 5 |
1 | NAMES OF REPORTING PERSONS: MPM BioVentures III Parallel Fund, L.P. |
||||
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY): | |||||
2 | CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS): |
||||
(a) o | |||||
(b) þ | |||||
3 | SEC USE ONLY: | ||||
4 | CITIZENSHIP OR PLACE OF ORGANIZATION: | ||||
Delaware | |||||
5 | SOLE VOTING POWER: | ||||
NUMBER OF | 172,441 | ||||
SHARES | 6 | SHARED VOTING POWER: | |||
BENEFICIALLY | |||||
OWNED BY | 0 | ||||
EACH | 7 | SOLE DISPOSITIVE POWER: | |||
REPORTING | |||||
PERSON | 172,441 | ||||
WITH: | 8 | SHARED DISPOSITIVE POWER: | |||
0 | |||||
9 | AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON: | ||||
172,441 | |||||
10 | CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS): | ||||
o | |||||
11 | PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9): | ||||
0.5% | |||||
12 | TYPE OF REPORTING PERSON (SEE INSTRUCTIONS): | ||||
PN |
Page 4 of 14
CUSIP No. |
88078l 10 5 |
1 | NAMES OF REPORTING PERSONS: MPM BioVentures III GmbH & Co. Beteiligungs KG |
||||
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY): | |||||
2 | CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS): |
||||
(a) o | |||||
(b) þ | |||||
3 | SEC USE ONLY: | ||||
4 | CITIZENSHIP OR PLACE OF ORGANIZATION: | ||||
Germany | |||||
5 | SOLE VOTING POWER: | ||||
NUMBER OF | 482,343 | ||||
SHARES | 6 | SHARED VOTING POWER: | |||
BENEFICIALLY | |||||
OWNED BY | 0 | ||||
EACH | 7 | SOLE DISPOSITIVE POWER: | |||
REPORTING | |||||
PERSON | 482,343 | ||||
WITH: | 8 | SHARED DISPOSITIVE POWER: | |||
0 | |||||
9 | AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON: | ||||
482,343 | |||||
10 | CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS): | ||||
o | |||||
11 | PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9): | ||||
1.5% | |||||
12 | TYPE OF REPORTING PERSON (SEE INSTRUCTIONS): | ||||
PN |
Page 5 of 14
CUSIP No. |
88078l 10 5 |
1 | NAMES OF REPORTING PERSONS: MPM Asset Management Investors 2002 BVII LLC |
||||
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY): | |||||
2 | CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS): |
||||
(a) o | |||||
(b) þ | |||||
3 | SEC USE ONLY: | ||||
4 | CITIZENSHIP OR PLACE OF ORGANIZATION: | ||||
Delaware | |||||
5 | SOLE VOTING POWER: | ||||
NUMBER OF | 112,772 | ||||
SHARES | 6 | SHARED VOTING POWER: | |||
BENEFICIALLY | |||||
OWNED BY | 0 | ||||
EACH | 7 | SOLE DISPOSITIVE POWER: | |||
REPORTING | |||||
PERSON | 112,772 | ||||
WITH: | 8 | SHARED DISPOSITIVE POWER: | |||
0 | |||||
9 | AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON: | ||||
112,772 | |||||
10 | CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS): | ||||
o | |||||
11 | PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9): | ||||
0.4% | |||||
12 | TYPE OF REPORTING PERSON (SEE INSTRUCTIONS): | ||||
OO |
Page 6 of 14
CUSIP No. |
88078l 10 5 |
1 | NAMES OF REPORTING PERSONS: Ansbert Gadicke |
||||
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY): | |||||
2 | CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS): |
||||
(a) o | |||||
(b) þ | |||||
3 | SEC USE ONLY: | ||||
4 | CITIZENSHIP OR PLACE OF ORGANIZATION: | ||||
United States | |||||
5 | SOLE VOTING POWER: | ||||
NUMBER OF | 0 | ||||
SHARES | 6 | SHARED VOTING POWER: | |||
BENEFICIALLY | |||||
OWNED BY | 6,859,268* | ||||
EACH | 7 | SOLE DISPOSITIVE POWER: | |||
REPORTING | |||||
PERSON | 0 | ||||
WITH: | 8 | SHARED DISPOSITIVE POWER: | |||
6,859,268* | |||||
9 | AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON: | ||||
6,859,268* | |||||
10 | CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS): | ||||
o | |||||
11 | PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9): | ||||
21.7% | |||||
12 | TYPE OF REPORTING PERSON (SEE INSTRUCTIONS): | ||||
IN |
Page 7 of 14
CUSIP No. |
88078l 10 5 |
1 | NAMES OF REPORTING PERSONS: Luke Evnin |
||||
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY): | |||||
2 | CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS): |
||||
(a) o | |||||
(b) þ | |||||
3 | SEC USE ONLY: | ||||
4 | CITIZENSHIP OR PLACE OF ORGANIZATION: | ||||
United States | |||||
5 | SOLE VOTING POWER: | ||||
NUMBER OF | 0 | ||||
SHARES | 6 | SHARED VOTING POWER: | |||
BENEFICIALLY | |||||
OWNED BY | 6,859,268* | ||||
EACH | 7 | SOLE DISPOSITIVE POWER: | |||
REPORTING | |||||
PERSON | 0 | ||||
WITH: | 8 | SHARED DISPOSITIVE POWER: | |||
6,859,268* | |||||
9 | AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON: | ||||
6,859,268* | |||||
10 | CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS): | ||||
o | |||||
11 | PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9): | ||||
21.7% | |||||
12 | TYPE OF REPORTING PERSON (SEE INSTRUCTIONS): | ||||
IN |
Page 8 of 14
Item 1. |
(a) | Name of Issuer |
(b) | Address of Issuers Principal Executive Offices |
Item 2. |
(a) | Name of Person Filing |
(b) | Address of Principal Business Office or, if none, Residence |
(c) | Citizenship |
(d) | Title of Class of Securities |
(e) | CUSIP Number |
Item 3. | If this statement is filed pursuant to §§240.13d-1(b), or 240.13d-2(b) or (c), check whether the person filing is a: |
Page 9 of 14
Item 4. | Ownership |
(a) | Amount Beneficially Owned: |
MPM BioVentures III, L.P. |
383,776 | |||
MPM BioVentures III-QP, L.P. |
5,707,936 | |||
MPM BioVentures III Parallel Fund, L.P. |
172,441 | |||
MPM BioVentures III GmbH & Co. Beteiligungs KG |
482,343 | |||
MPM Asset Management Investors 2002 BVIII LLC |
112,772 | |||
Ansbert Gadicke |
6,859,268 | * | ||
Luke Evnin |
6,859,268 | * |
MPM BioVentures III, L.P. |
1.2 | % | ||
MPM BioVentures III-QP, L.P. |
18.0 | % | ||
MPM BioVentures III Parallel Fund, L.P. |
0.5 | % | ||
MPM BioVentures III GmbH & Co. Beteiligungs KG |
1.5 | % | ||
MPM Asset Management Investors 2002 BVIII LLC |
0.4 | % | ||
Ansbert Gadicke |
21.7 | % | ||
Luke Evnin |
21.7 | % |
(b) | Number of shares as to which the person has: |
(i) | Sole power to vote or to direct the vote |
MPM BioVentures III, L.P. |
383,776 | |||
MPM BioVentures III-QP, L.P. |
5,707,936 | |||
MPM BioVentures III Parallel Fund, L.P. |
172,441 | |||
MPM BioVentures III GmbH & Co. Beteiligungs KG |
482,343 | |||
MPM Asset Management Investors 2002 BVIII LLC |
112,772 | |||
Ansbert Gadicke |
0 | |||
Luke Evnin |
0 |
Page 10 of 14
(ii) | Shared power to vote or to direct the vote |
MPM BioVentures III, L.P. |
0 | |||
MPM BioVentures III-QP, L.P. |
0 | |||
MPM BioVentures III Parallel Fund, L.P. |
0 | |||
MPM BioVentures III GmbH & Co. Beteiligungs KG |
0 | |||
MPM Asset Management Investors 2002 BVIII LLC |
0 | |||
Ansbert Gadicke |
6,859,268 | * | ||
Luke Evnin |
6,859,268 | * |
(iii) | Sole power to dispose or to direct the disposition of |
MPM BioVentures III, L.P. |
383,776 | |||
MPM BioVentures III-QP, L.P. |
5,707,936 | |||
MPM BioVentures III Parallel Fund, L.P. |
172,441 | |||
MPM BioVentures III GmbH & Co. Beteiligungs KG |
482,343 | |||
MPM Asset Management Investors 2002 BVIII LLC |
112,772 | |||
Ansbert Gadicke |
0 | |||
Luke Evnin |
0 |
(iv) | Shared power to dispose or to direct the disposition of |
MPM BioVentures III, L.P. |
0 | |||
MPM BioVentures III-QP, L.P. |
0 | |||
MPM BioVentures III Parallel Fund, L.P. |
0 | |||
MPM BioVentures III GmbH & Co. Beteiligungs KG |
0 | |||
MPM Asset Management Investors 2002 BVIII LLC |
0 | |||
Ansbert Gadicke |
6,859,268 | * | ||
Luke Evnin |
6,859,268 | * |
Item 5. | Ownership of Five Percent or Less of a Class |
Item 6. | Ownership of More than Five Percent on Behalf of Another Person |
Page 11 of 14
Item 7. | Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company or Control Person. |
Item 8. | Identification and Classification of Members of the Group |
Item 9. | Notice of Dissolution of a Group |
Item 10. | Certification |
Page 12 of 14
MPM BIOVENTURES III, L.P. | MPM BIOVENTURES III-QP, L.P. | |||||
By:
|
MPM BioVentures III GP, L.P., | By: | MPM BioVentures III GP, L.P., | |||
its General Partner | its General Partner | |||||
By:
|
MPM BioVentures III LLC, | By: | MPM BioVentures III LLC, | |||
its General Partner | its General Partner | |||||
By:
|
\s\ Luke Evnin |
By: | \s\ Luke Evnin |
|||
Name: Luke Evnin | Name: Luke Evnin | |||||
Title: Series A Member | Title: Series A Member | |||||
MPM BIOVENTURES III PARALLEL FUND, L.P. | MPM BIOVENTURES III GMBH & CO. BETEILIGUNGS KG | |||||
By:
|
MPM BioVentures III GP, L.P., | By: | MPM BioVentures III GP, L.P., | |||
its General Partner | in its capacity as the Managing Limited Partner | |||||
By:
|
MPM BioVentures III LLC, | By: | MPM BioVentures III LLC, | |||
its General Partner | its General Partner | |||||
By:
|
\s\ Luke Evnin
|
By: | \s\ Luke Evnin |
|||
Name: Luke Evnin | Name: Luke Evnin | |||||
Title: Series A Member | Title: Series A Member | |||||
MPM ASSET MANAGEMENT INVESTORS 2002 BVIII LLC | ||||||
By:
|
\s\ Luke Evnin
|
By: | \s\ Ansbert Gadicke |
|||
Name: Luke Evnin | Name: Ansbert Gadicke | |||||
Title: Manager | ||||||
By:
|
\s\ Luke Evnin |
|||||
Name: Luke Evnin |
Page 13 of 14
MPM BIOVENTURES III, L.P. | MPM BIOVENTURES III-QP, L.P. | |||||
By:
|
MPM BioVentures III GP, L.P., | By: | MPM BioVentures III GP, L.P., | |||
its General Partner | its General Partner | |||||
By:
|
MPM BioVentures III LLC, | By: | MPM BioVentures III LLC, | |||
its General Partner | its General Partner | |||||
By:
|
\s\ Luke Evnin
|
By: | \s\ Luke Evnin |
|||
Name: Luke Evnin | Name: Luke Evnin | |||||
Title: Series A Member | Title: Series A Member | |||||
MPM BIOVENTURES III PARALLEL FUND, L.P. | MPM BIOVENTURES III GMBH & CO. BETEILIGUNGS KG | |||||
By:
|
MPM BioVentures III GP, L.P., | By: | MPM BioVentures III GP, L.P., | |||
its General Partner | in its capacity as the Managing Limited Partner | |||||
By:
|
MPM BioVentures III LLC, | By: | MPM BioVentures III LLC, | |||
its General Partner | its General Partner | |||||
By:
|
\s\ Luke Evnin
|
By: | \s\ Luke Evnin |
|||
Name: Luke Evnin | Name: Luke Evnin | |||||
Title: Series A Member | Title: Series A Member | |||||
MPM ASSET MANAGEMENT INVESTORS 2002 BVIII LLC | ||||||
By:
|
\s\ Luke Evnin
|
By: | \s\ Ansbert Gadicke |
|||
Name: Luke Evnin | Name: Ansbert Gadicke | |||||
Title: Manager | ||||||
By:
|
\s\ Luke Evnin |
|||||
Name: Luke Evnin |
Page 14 of 14